Valerie Vanhooren is the founder of Ona Therapeutics. Ona Therapeutics has raised $117M in total funding. Latest round: Series B. Based in Barcelona, Spain.
Valerie Vanhooren, PhD, is the co-founder and CEO of Ona Therapeutics, a global biopharmaceutical company pioneering first-in-class antibody-drug conjugates (ADCs) for treatment-resistant cancers. Since 2019, she has guided the development of Ona's pipeline and secured over €35 million from international investors and non-dilutive grants, advancing the company toward clinical-stage operations.
Full founder directory · Investor directory · Company funding database · Fundraising library